Partner with us to speed up the adoption of the multispectral plasmonic pixel. Talk to us about licensing or direct investment.
The technology
This is a new pixel design based on plasmonic nanostructures. It can detect the intensity of light across many wavelengths.
Market need
Demand for slimmer and more compact digital imaging devices, particularly in smartphones, are driving the need for advances in pixel design.
Existing pixel designs rely on a colour filter to discern the wavelength of light. This limits the capacity to miniaturise digital-imaging devices further and requires significant post-processing.
Technology status
Proof-of-concept fabrication of three- and six-channel pixels shows they can discern the intensity of light. This ranges from ultraviolet to near-infrared.
Plasmonic Pixel flyer (PDF 695.6 KB)
Research by James et al. (2016) DOI: 10.1021/acs.nanolett.6b01250
- Contact
- Fabian Lim
- info@unimelb.edu.au
- Phone
- +61 3 9035 6020
Banner image: An image (left) produced by plasmonic pixels showed that colours could be accurately reproduced using a straightforward colour-mapping algorithm. This iconic image from 1975 depicts then Prime Minister Gough Whitlam pouring soil into the hand of Vincent Lingiari, a Gurindji elder. This gesture symbolised the return of ancestral lands to traditional landowners. Image provided by the The Art Gallery of New South Wales.
First published on 21 July 2020.
Share this article
Research commercialisation opportunitiesResearch Innovation and Commercialisation
Keep reading
-
CCL17
Recently licensed: A company has partnered with us to develop a new pain treatment technology that blocks CCL17 expression.
-
Plasmonic pixel
Partner with us to speed up the adoption of the multispectral plasmonic pixel. Talk to us about licensing or direct investment.
-
Predicting landslides
New open-pit mining technology can predict landslides up to 15 days in advance.
-
Severe asthma therapy
Recently licensed: A start-up has partnered with us to accelerate the development of a therapy for steroid-resistant asthma.